Search results
1 company and 7 research reports found for "Merrion Pharmaceuticals"
Company results
- Merrion Pharmaceuticals
Merrion is an Irish company that uses technology acquired from Elan to reformulate injectable drugs ...
Sector reports
No sector reports have been found.
Research results
Merrion Pharmaceuticals
Portals to discovery
Update | Pharmaceutical & Healthcare | 21/03/2011Merrion’s final results for 2010 show a business gearing up to run a set of projects to discover new pharmaceutical formulations. The CityWest facil...
Merrion Pharmaceuticals
Project diversification
Outlook | Pharmaceutical & Healthcare | 28/02/2011Merrion has signed three evaluation contracts, including Novo and a top 10 pharma to use its delivery technology for up to six products. This should g...
Merrion Pharmaceuticals
Switch to breast cancer
Update | Pharmaceutical & Healthcare | 19/11/2010An FDA review has switched Orazol’s development plan in the US from bone metastases, the indication agreed with the CHMP, to adjuvant early-stage br...
Merrion Pharmaceuticals
Imminent deals
Update | Pharmaceutical & Healthcare | 11/03/2010Merrion transforms injected drugs into oral pharmaceuticals, offering relatively low development risk with minimal marketing uncertainty. Final FY09 r...
Merrion Pharmaceuticals
Oral insulin goes clinical
Update | Pharmaceutical & Healthcare | 11/12/2009Merrion Pharmaceuticals’ value proposition has improved markedly with two recent events. Novo has started Phase I trials of oral insulin. Althoug...
Merrion Pharmaceuticals
Raising its profile
Update | Pharmaceutical & Healthcare | 05/11/2009Merrion is raising its corporate profile with a move to new facilities that should allow a significant scale up of its R&D activities. Meanwhile, it c...
Merrion Pharmaceuticals
Nil by needle
Outlook | Pharmaceutical & Healthcare | 14/09/2009Merrion transforms injected drugs into oral pharmaceuticals, offering relatively low development risk with minimal regulatory and marketing uncertaint...
